Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose.

ABSTRACT:

Importance

As opioid-related mortality continues to increase, naloxone remains a critical intervention in preventing overdose death. Opportunities to expand access through the health care setting should be optimized.

Objective

To determine the characteristics of naloxone prescribing for US patients at high risk of opioid overdose.

Design, setting, and participants

This retrospective cohort study used Truven Health MarketScan data from October 1, 2015, through December 31, 2016, of individuals with International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes related to opioid use, misuse, dependence, and overdose. The cohort included 138 108 commercially insured individuals aged 15 years or older in the United States with claim

SUBMITTER: Follman S 

PROVIDER: S-EPMC6503491 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature